"BioNano Genomics Inc (NASDAQ: BNGO) is running for the top in the market this morning, and for good reason. The company announced the publication of a study on autism risk genes. Here’s what’s going on . . . "Final Thoughts . . . While any investment comes with risk, an investment in BioNano Genomics at the moment is worth consideration. At the end of the day, the company is working to solve one of the most pressing and prevalent problems in children’s medicine today, autism spectrum disorder. "While the disorder is very difficult to treat, data from this study will ultimately help BNGO find solutions for this vast patient population, making the stock one that’s hard to ignore."